Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ: MDGL · Real-Time Price · USD
373.46
+14.46 (4.03%)
At close: Aug 13, 2025, 4:00 PM
373.46
0.00 (0.00%)
After-hours: Aug 13, 2025, 6:30 PM EDT
Madrigal Pharmaceuticals Analyst Ratings
Total Analysts
8
Consensus Rating
Strong Buy
Price Target
$439.71
Upside
+17.74%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Buy Maintains $458 → $523 | Strong Buy | Maintains | $458 → $523 | +40.04% | Aug 12, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $420 → $428 | Strong Buy | Maintains | $420 → $428 | +14.60% | Aug 6, 2025 |
| UBS | UBS | Strong Buy Maintains $441 → $458 | Strong Buy | Maintains | $441 → $458 | +22.64% | May 2, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $422 → $460 | Strong Buy | Reiterates | $422 → $460 | +23.17% | May 2, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $394 → $420 | Strong Buy | Maintains | $394 → $420 | +12.46% | May 2, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $443 | Buy | Reiterates | $443 | +18.62% | Apr 24, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $378 → $469 | Strong Buy | Maintains | $378 → $469 | +25.58% | Feb 27, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $400 → $405 | Strong Buy | Maintains | $400 → $405 | +8.45% | Feb 27, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $390 → $400 | Strong Buy | Maintains | $390 → $400 | +7.11% | Jan 14, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $427 | Buy | Reiterates | $427 | +14.34% | Jan 10, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 20, 2024 |
| B. Riley Securities | B. Riley Securities | Hold Maintains $194 → $236 | Hold | Maintains | $194 → $236 | -36.81% | Nov 5, 2024 |
| UBS | UBS | Strong Buy Maintains $411 → $441 | Strong Buy | Maintains | $411 → $441 | +18.08% | Nov 1, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $375 → $350 | Buy | Maintains | $375 → $350 | -6.28% | Oct 23, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $390 | Strong Buy | Reiterates | $390 | +4.43% | Oct 22, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Oct 11, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.